NCT01284686

Brief Summary

Neuronal activity in circuits between the basal ganglia (BG) and motor cortical areas is abnormally synchronised and rhythmic. The oscillatory activity prevails at 8-30 Hz in untreated Parkinson's Disease (PD) and its amplitude at both subthalamic and cortical levels inversely correlates with motor impairment. Moreover, these different levels in BG-cortical loops are coherent in this frequency band. The 8-30 Hz activity is suppressed by treatment following treatment with dopaminergic drugs and is partially suppressed prior to and during voluntary movements. An unanswered question is how do BG-cortical loops become so prominently engaged in this oscillatory activity? One possible explanation is that the resonance frequencies of the loops fall in the 8-30 Hz band in the untreated state, so that oscillations in this band are transmitted particularly well. This hypothesis was confirmed in a previous series of experiments.The aim is to determine whether the resonance frequency within BG-cortical loops is correlated to the BG-cortical coherence frequency (with 20 subjets during 24 months).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 27, 2011

Completed
1.2 years until next milestone

Study Start

First participant enrolled

March 26, 2012

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 27, 2015

Completed
Last Updated

May 7, 2026

Status Verified

July 1, 2022

Enrollment Period

3.2 years

First QC Date

January 26, 2011

Last Update Submit

May 4, 2026

Conditions

Keywords

PathophysiologyParkinsonneuronal oscillations

Outcome Measures

Primary Outcomes (1)

  • the understanding of the mechanisms underlying the propagation of pathological oscillatory activities in PD

    24 months

Secondary Outcomes (1)

  • may provide a basis for different therapeutic strategies

    24 months

Study Arms (2)

dopamine

ACTIVE COMPARATOR

ON DOPA:The patient will take his usual treatment with dopamine

Other: subthalamo-cortical loops stimulation in a one-sided and bipolar way

without dopa

EXPERIMENTAL

OFF Dopa: The patient will be deprived of his treatment usual dopaminergique for at least 12 hours

Other: subthalamo-cortical loops stimulation in a one-sided and bipolar way

Interventions

Record STN-cortex LFP coherence pattern and then stimulate STN (at 0, 5, 10, 15, 20, 25, 30 Hz) in newly implanted patients

dopamine

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Parkinson's disease idiopathique evolving for more than 5 years
  • Dopa-Sensibility superior to 50 %
  • Electrodes of stimulation implanted in 2 NST at Timone (Pr PERAGUT)

You may not qualify if:

  • Bad tolerance of the condition OFF Dopa and\\or OFF stimulation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

APHM

Marseille, 13, France

Location

Related Publications (1)

  • Azulay JP, Witjas T, Eusebio A. Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson's disease. J Neural Transm (Vienna). 2013 Apr;120(4):655-7. doi: 10.1007/s00702-012-0958-9. Epub 2012 Dec 23.

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Jean-Philippe AZULAY

    APHM

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2011

First Posted

January 27, 2011

Study Start

March 26, 2012

Primary Completion

May 27, 2015

Study Completion

May 27, 2015

Last Updated

May 7, 2026

Record last verified: 2022-07

Locations